Navigation Links
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Date:5/4/2009

.

The therapeutic areas on which Almirall focuses its research resources are related to the treatment of asthma, COPD (chronic obstructive pulmonary disease), rheumatoid arthritis, multiple sclerosis, psoriasis, and dermatology. The company is also aiming to expand its development pipeline though licensing-in in the areas mentioned plus some others including gastrointestinal and neurology.

Almirall is currently present in over 70 countries with direct presence in Europe and Latin America through 11 affiliates (Austria, Belgium, France, Germany, Italy, Mexico, Poland, Portugal, Spain, Switzerland, and the UK-Ireland). For further information please visit the website at: www.almirall.com.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (www.ironwoodpharma.com) is an entrepreneurial pharmaceutical company dedicated to the science and art of great drugmaking. Linaclotide, the company's first in class compound, is being evaluated in a comprehensive Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Microbia, Inc. (formerly Microbia Precision Engineering), a majority-owned subsidiary of Ironwood, is an industrial biotechnology company developing and commercializing novel bioprocesses for the production of specialty chemicals. Ironwood has raised $281 million in private equity financing and is located in Cambridge, Massachusetts.

    Contact:
    Susan Brady
    Corporate Communications
    617.621.8304
    sbrady@ironwoodpharma.com


'/>"/>
SOURCE Ironwood Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
5. Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... BOCA RATON, Fla. , Nov. 24, 2014  Marta ... Aesthetic Medicine, Boca Raton , FL and international ... dermatologic physicians selected from the United States ... 14-16 in Istanbul, Turkey . Here, at ... truly meet West, as world renowned facial plastic surgery experts ...
(Date:11/24/2014)... Theater, LLC, announced today that their technology will be ... Europe,s first simulation center, The ... Planner (SRP) and the Surgical Navigation Advanced Platform (SNAP) ... navigation and augmented reality capabilities in the operating room ... Department of Neurosurgery at Mount Sinai Health System in ...
(Date:11/24/2014)... 2014  Pifflers United Chronic and Invisible Illnesses ... of results of a study of ActiPatch®, a ... of fibromyalgia pain. The results demonstrated that when ... significant clinically meaningful pain reduction can be achieved. ... fibromyalgia used ActiPatch® for 7 days and were ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... , , , , WOONSOCKET, R.I., Jan. 8 ... (NYSE: CVS ) and the pioneer and largest ... become the first retail clinic to be re-accredited and earn ... periods by having demonstrated compliance with The Joint Commission,s national ...
... SOUTH SAN FRANCISCO, Dec. 31 Anesiva, Inc. (Nasdaq: ... the closing conditions set forth in the Agreement and Plan ... Corporation, a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") ... the agreement, each of the Arcion stockholders listed on Schedule ...
Cached Medicine Technology:CVS Caremark's MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission 2CVS Caremark's MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission 3CVS Caremark's MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission 4Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed 2
(Date:11/26/2014)... November 26, 2014 For its ... published The AIS Report on Blue Cross and Blue ... Inc. on the varied strategies the two Blues plans ... compliance with treatments for sleep apnea, ranging from brick-and-mortar ... because it’s linked to increased rates of a variety ...
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... 2014 Anthropologists have identified concrete ... and stopping Ebola, improve international support, and pave ... in West Africa. , The report, “Strengthening ... Anthropologists Offer Insights,” will be made public during ... Association (AAA), Fri., Dec. 5, 11 a.m., at ...
(Date:11/26/2014)... For those with a New Year’s resolution ... BODYPUMP™ classes at the University of Colorado Anschutz Health ... looking for. The 45- 60 minute classes have just started ... Center fitness club memberships. , LES MILLS BODYPUMP™ exercise classes ... are aimed at fast results , By focusing on ...
(Date:11/26/2014)... of the most important and vital decisions a woman ... choosing the ideal wedding dress and bridesmaid dresses. BellasDress.com ... quality outfits. Today, BellasDress.com has unveiled its new range ... suitable bridesmaid gowns here at discount prices. , Formal ... and highlight all their most beautiful features while drawing ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2
... YORK, April 15 An internationally-known brand name,New York ... Bruce,of Wellness" by Shape magazine, Susan Powter,s "Stop the ... personal story of losing over,l30 pounds as a single ... and fitness industry forever. Now, recently returned to public,life ...
... YARDLEY, Pa., April 15 Breakaway Technologies, Inc.,(BTI), ... that 2008 marks its 10th anniversary. BTI has ... 10 years., "Breakaway was founded to provide ... problems, whether they needed a technology or a,business ...
... diuretics more than double risk for fractures, study finds ... drugs commonly prescribed to treat heart failure and hypertension, ... men, says a U.S. study. , Researchers evaluated 3,269 ... examination between 2000 and 2002, with a follow-up visit ...
... and CAMARILLO, Calif., April 15 IBM (NYSE:,IBM) ... today announced GSMS will be ready to comply ... GSMS is using,IBM technology to manage serialized drug ... The California Board of Pharmacy recently gave ...
... Adults with Autism and Other ... ... annual,in-store fundraising and awareness campaign to bring new hope and,opportunities to ... of dollars to fund Easter Seals, autism and,disability services, provide job ...
... 15, 2008 -- Results of a phase IV, open ... subcutaneous Rebif (interferon beta-1a) provide clinical evidence that the ... months of continued therapy in patients with relapsing-remitting multiple ... April 2008 issue of the Current Medical Research and ...
Cached Medicine News:Health News:Susan Powter The Politics of Stupid: The Cure for Obesity 2Health News:Breakaway Technologies Celebrates 10 Years in Business 2Health News:Heart Failure Drugs Linked to Hip Bone Loss in Older Men 2Health News:Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations 2Health News:Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations 3Health News:Safeway's In-Store Disabilities Campaign to Benefit Easter Seals 2Health News:Study shows that high-dose, high-frequency interferon produces no additional benefit 2
... eyewear designs with children in mind, making ... and stay-put cable temples. Its not surprising ... Research as the best selling childrens collection ... so popular is its ability to keep ...
Inquire...
... new GUCCI DONNA eyewear collection celebrates the ... a vintage yet contemporary feel, the unmistakable ... new GUCCI UOMO optical and sunglass collection, ... classic lines with cutting-edge design that is ...
Inquire...
Medicine Products: